Be the first to like this
Presentation: The Powerful Voice of Advocacy and Communications in Specialty Pharma
In specialty pharma, connecting patients with needed care -- and with each other -- can be a special challenge. About 50 percent of rare diseases are so small that they do not have a dedicated organization to provide patient support, conduct research, or advocate for increased research funding. This session will review recent trends in how advocacy and communications play a critical role globally in the advance of innovative treatments - especially for the world's smallest patient populations - to impact patient care and outcomes.
Presented by: Gil Bashe, Executive Vice President and Health Practice Director, Makovsky